SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-23-000113
Filing Date
2023-08-02
Accepted
2023-08-02 16:02:49
Documents
1
Period of Report
2023-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1691006558.html 4  
1 FORM 4 wk-form4_1691006558.xml 4 7086
  Complete submission text file 0001439222-23-000113.txt   8548
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Washburn Theodore James Jr. (Reporting) CIK: 0001874199 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 231135425